Comments
Loading...
Celcuity (NASDAQ:CELC) Stock Quotes, Forecast and News Summary
Celcuity Stock (NASDAQ: CELC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Celcuity (CELC) stock?
You can purchase shares of Celcuity (NASDAQ:CELC) through any online brokerage.
Who are Celcuity (CELC) competitors?
Other companies in Celcuity’s space includes: KalVista Pharma (NASDAQ:KALV), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO), Larimar Therapeutics (NASDAQ:LRMR) and Pharming (NASDAQ:PHAR).
What is the forecast, or price target, for Celcuity (CELC) stock?
Celcuity has a consensus price target of $29.17.
What is the current price for Celcuity (CELC)?
The stock price for Celcuity (NASDAQ: CELC) is $12.505 last updated December 3, 2024 at 12:30 PM EST.
Does Celcuity (CELC) pay a dividend?
There are no upcoming dividends for Celcuity.
When is Celcuity (NASDAQ:CELC) reporting earnings?
Celcuity’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Celcuity (CELC) going to split?
There is no upcoming split for Celcuity.
What sector and industry does Celcuity (CELC) operate in?
Celcuity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.